arrow
返回

Hepatitis C screening: Getting it right

delete2013-04-01
delete11
delete
OA
AI
B
Brian R. Edlin *
DOI:10.1002/hep.26194delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Hepatitis C is the most prevalent bloodborne viral disease in the United States and the deadliest. This year, the U.S. Preventive Services Task Force (USPSTF) will update its 2004 hepatitis C guideline, which recommends against screening asymptomatic adults for hepatitis C. This guideline has hampered public health efforts to encourage screening and identify and refer infected persons for care by declaring that such interventions were not supported by the evidence. A draft revision of the guideline, released on November 26, 2012, concludes that testing persons born between 1945 and 1965 probably has at least a small net benefit, but stops short of definitively recommending that this cohort be screened. This article examines the Task Force's process for writing its guidelines. It recommends that the Task Force adopt a balanced approach to evaluating the benefits and harms of screening; use the preponderance of the evidence as a standard for evaluating interventions that target serious public health problems; be transparent about the value judgments that go into its decisions; consider the wide variation in disease prevalence in diverse patient populations; and recommend screening asymptomatic adults for hepatitis C. Conclusion: By taking a broader view of the evidence, the Task Force can write new guidelines that will serve efforts to curb the hepatitis C epidemic, rather than frustrate them. (HEPATOLOGY 2013)
Keyword:
SERVICES-TASK-FORCE
SUSTAINED VIROLOGICAL RESPONSE
VIRUS-INFECTION
UNITED-STATES
HEPATOCELLULAR-CARCINOMA
RACIAL-DIFFERENCES
COST-EFFECTIVENESS
MORTALITY
RECOMMENDATION
OUTCOMES
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Hepatology 封面图
Hepatology
IF:
15.8
论文数:
2.0W
被引数:
7.2W

机构

N
national development & research institutes, inc
学者数:
187
论文数: 173
被引数: 0
引用论文

引用论文

Exclusive C−Si Bond Formation upon Reaction of a Platinum(II) Alkyl with Silanes
err1998-08-22
err0
PREAI
errMilko E. van der Boom; Jürgen Ott; David Milstein
err分享
err收藏
Breast Cancer Screening: From Science to Recommendation
errRADIOLOGY
IF15.2
err2010-07-01
err15
PREAI
errPetitti, Diana B.; Calonge, Ned; LeFevre, Michael L.; Melnyk, Bernadette Mazurek; Wilt, Timothy J.; Schwartz, J. Sanford
err分享
err收藏
Effect of Hepatitis C Virus and Its Treatment on Survival
err2009-08-01
err76
PREAI
errButt, Adeel A.; Wang, Xiaoqiang; Moore, Charity G.
err分享
err收藏
A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
err2010-11-01
err282
errOAAI
errSwain, Mark G.; Lai, Ming-Yang; Shiffman, Mitchell L.; Cooksley, W. Graham E.; Zeuzem, Stefan; Dieterich, Douglas T.; Abergel, Armand; Pessoa, Mario G.; Lin, Amy; Tietz, Andreas; Connell, Edward V.; Diago, Moises
err分享
err收藏
The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
err2012-02-21
err651
PREAI
errLy, Kathleen N.; Xing, Jian; Klevens, R. Monina; Jiles, Ruth B.; Ward, John W.; Holmberg, Scott D.
err分享
err收藏
Cancer Screening Campaigns - Getting Past Uninformative Persuasion癌症筛查活动-摆脱无信息的说服
err2012-11-01
err72
PREAI
errWoloshin, Steven; Schwartz, Lisa M.; Black, William C.; Kramer, Barnett S.
err分享
err收藏
Racial differences in the evaluation and treatment of hepatitis C among veterans: A retrospective cohort study
err2008-05-01
err35
errOAAI
errRousseau, Christine M.; Ioannou, George N.; Todd-Stenberg, Jeffrey A.; Sloan, Kevin L.; Larson, Meaghan F.; Forsberg, Christopher W.; Dominitz, Jason A.
err分享
err收藏
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002
err2008-01-01
err77
PREAI
errSiegel, Abby B.; McBride, Russell B.; El-Serag, Hashem B.; Hershman, Dawn L.; Brown, Robert S.; Renz, John F.; Emond, Jean, Jr.; Neugut, Alfred I.
err分享
err收藏
学者 查看更多内容